Disclosed positions

Estimated from their latest filings — positions may have changed since

$565.1K

combined est. value

Stock	Shares	Price	Value	Weight	As of
NTLAIntellia Therapeutics, Inc.	33,559	$16.84	$565.1K	100%	2026-06-09

NTLA

Intellia Therapeutics, Inc.

$565.1K

33,559 sh

All filings on record

Every Form 4 transaction we track for this filer

all 4buys 0sells 2

Stock	Transaction	Date	~6mo later
NTLAIntellia Therapeutics, Inc.	Grant — · 9,200 sh	2026-06-09	—
NTLAIntellia Therapeutics, Inc.	Sell $14.3K · 1,547 sh	2025-07-01	—
NTLAIntellia Therapeutics, Inc.	Sell $14.8K · 1,547 sh	2025-06-30	—
NTLAIntellia Therapeutics, Inc.	Grant — · 8,000 sh	2025-06-11	—

NTLAGrant

2026-06-09 · Intellia Therapeutics, Inc.

9,200

—

NTLASell

2025-07-01 · Intellia Therapeutics, Inc.

$14.3K

—

NTLASell

2025-06-30 · Intellia Therapeutics, Inc.

$14.8K

—

NTLAGrant

2025-06-11 · Intellia Therapeutics, Inc.

8,000

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.